Latest filing published 13 Apr 2017 for Neurocrine Biosciences INC, €64k.
Insider track record
Joseph A. Mollica: trading record in brief
Joseph A. Mollica is a declared insider at 3 companies; the most frequent names are Pharmacopeia Drug Discovery Inc, Neurocrine Biosciences Inc and Cytogen Corp. In total, 62 filings cover trades dated from 26 February 2007 to 12 April 2017.
On the market, this insider has only sold: 18 sales, €391k in total. Outside the open market, there are 13 share grants and 23 option exercises.
Most recently, on 13 April 2017, the filings show an option exercise worth €64k in Neurocrine Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph A. Mollica
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$3.4050.0% of flowCommon StockSEC:0001209191-17-026899:0
- 1,312 shares@ US$51.8050.0% of flowCommon StockSEC:0001209191-17-026899:1
- 20,000 sharesCommon StockSEC:0001209191-16-097997:0
- 1,821 sharesCommon StockSEC:0001209191-16-097997:1
- 20,000 shares@ US$4.76Common StockSEC:0000914475-14-000094:0
- 4,333 shares@ US$21.97Common StockSEC:0000914475-14-000094:1
- 15,000 shares@ US$12.37Common StockSEC:0000914475-14-000031:0
- 13,406 shares@ US$13.84Common StockSEC:0000914475-14-000031:1
- 15,000 shares@ US$10.60Common StockSEC:0000914475-13-000019:0
- 13,086 shares@ US$12.15Common StockSEC:0000914475-13-000019:1
- 141,977.07 sharesCommon StockSEC:0001273013-08-000072:0
- 1,124.99 shares@ US$0.87Common StockSEC:0001273013-08-000067:0
- 679.54 shares@ US$1.49Common StockSEC:0001273013-08-000064:0
- 482.15 shares@ US$2.10Common StockSEC:0001273013-08-000061:0
- 309.63 shares@ US$3.27Common StockSEC:0001287711-08-000006:0
- 414.16 shares@ US$3.83Common StockSEC:0001273013-08-000053:0
- 266.24 shares@ US$4.31Common StockSEC:0001273013-08-000046:0
- 55,000 shares0Common StockSEC:0001273013-08-000045:0
- 2,000 sharesCommon StockSEC:0001140361-08-011719:0
- 10,000 sharesCommon StockSEC:0001140361-08-011719:1
- 8,399 shares@ US$2.82Common StockSEC:0001126489-07-000009:0
- 8,399 shares@ US$5.60Common StockSEC:0001126489-07-000009:1
- 5,000 shares@ US$2.82Common StockSEC:0001126489-07-000008:0
- 5,000 shares@ US$5.73Common StockSEC:0001126489-07-000008:1
- 5,000 shares@ US$2.82Common StockSEC:0001126489-07-000007:0
25 of 58 declarations
